Ignite Creation Date:
2025-12-24 @ 5:56 PM
Ignite Modification Date:
2026-02-22 @ 12:08 AM
Study NCT ID:
NCT01401868
Status:
COMPLETED
Last Update Posted:
2013-06-24
First Post:
2011-07-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Dose Escalation Study of the Safety and Pharmacokinetics of ME-143 Single Agent for Refractory Solid Tumors
Sponsor:
MEI Pharma, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ME-143-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |